Fig. 4From: UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective studySurvival in cervical cancer patients based on FIGO stage. a Progression-free survival (PFS) and b overall survival (OS)Back to article page